New drug application
Aphexda Lyophilized Powder for Solution for Injection 62mg/ml
27 August 2026
The summary report for this therapeutic product is available for download
Summary report for Aphexda
Active ingredient | Product Registrant | Approval date | Summary report |
|---|---|---|---|
Motixafortide | DCH Auriga Singapore | 8 June 2026 |
